Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements

Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements This document provides guidance on establishment licensing, product quality and lot release to bring a COVID-19 vaccine to market in Canada. 2022-07-28 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19SARS-CoV-2 virusCOVID-19 vaccinesCOVID-19 drugsmarket authorization requirementsvaccine manufacturersestablishment licensingproduct quality Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirementsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines/quality-manufacturing-lot-release-requirements.html Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirementsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/exigences-qualite-fabrication-autorisation-circulation-lots.html

This document provides guidance on establishment licensing, product quality and lot release to bring a COVID-19 vaccine to market in Canada.

Data and Resources

Similar records